Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer Netherlands

9781402062513

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_32 ◽

2007 ◽

pp. 238-250

Author(s):

R. W. Chapman

Keyword(s):

Ursodeoxycholic Acid ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

High Dose

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_30 ◽

2007 ◽

pp. 221-225

Author(s):

K. D. Lindor

Keyword(s):

Ursodeoxycholic Acid ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis

Evidence for a role of the FXR-driven intestinal regulatory factor FGF-19 upon cholestyramine and chenodeoxycholic acid treatment and during the diurnal regulation of bile acid synthesis in humans

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_13 ◽

2007 ◽

pp. 92-96

Author(s):

M. Rudling ◽

T. Lundasen ◽

B. Angelin ◽

C. Gälman

Keyword(s):

Bile Acid ◽

Chenodeoxycholic Acid ◽

Acid Treatment ◽

Acid Synthesis ◽

Bile Acid Synthesis ◽

Regulatory Factor ◽

Diurnal Regulation

Insights into the regulation of expression of human OSTα-OSTβ

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_7 ◽

2007 ◽

pp. 53-56

Author(s):

C. J. Soroka ◽

S. Xu ◽

S.-Y. Cai ◽

N. Ballatori ◽

J. L. Boyer

Keyword(s):

Regulation Of Expression

Role of polymorphisms in genes involved in bile acid detoxification pathways in primary sclerosing cholangitis

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_31 ◽

2007 ◽

pp. 226-237

Author(s):

T. H. Karlsen ◽

K. M. Boberg ◽

E. Schrumpf

Keyword(s):

Bile Acid ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Detoxification Pathways

Ursodeoxycholic acid-disulphate (SUDCA) — a potent chemopreventive agent against colon cancer

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_27 ◽

2007 ◽

pp. 194-200 ◽

Cited By ~ 1

Author(s):

K. D. R. Setchell ◽

N. M. Brown ◽

K. Bove

Keyword(s):

Colon Cancer ◽

Ursodeoxycholic Acid ◽

Chemopreventive Agent

Bile acids enhance cellular motility of the hepatic myofibroblast-like cell through the regulation of p38/JNK signalling

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_25 ◽

2007 ◽

pp. 179-184

Author(s):

Y. Zhang ◽

T. Ikegami ◽

A. Honda ◽

B. Bouscarel ◽

Y. Matsuzaki

Keyword(s):

Bile Acids ◽

Cellular Motility

Primary sclerosing cholangitis: bile duct and colonie carcinomas after long-term ursodeoxycholic acid

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_33 ◽

2007 ◽

pp. 251-255

Author(s):

A. Stiehl ◽

D. Rost ◽

H. Kulaksiz

Keyword(s):

Bile Duct ◽

Ursodeoxycholic Acid ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis

Prevention of cholesterol gallstones by the potent cholesterol absorption inhibitor ezetimibe in gallstone-susceptible C57L/J mice

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_28 ◽

2007 ◽

pp. 201-214

Author(s):

H. H. Wang ◽

P. Portincasa ◽

D. Q.-H. Wang

Keyword(s):

Cholesterol Absorption ◽

Cholesterol Gallstones ◽

Cholesterol Absorption Inhibitor

Adolf windaus prize lecture: primary biliary cirrhosis: from ursodeoxycholic acid towards targeting strategies for therapies

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance ◽

10.1007/978-1-4020-6252-0_22 ◽

2007 ◽

pp. 156-166

Author(s):

R. Poupon

Keyword(s):

Primary Biliary Cirrhosis ◽

Ursodeoxycholic Acid ◽

Biliary Cirrhosis

Falk Symposium - Bile Acids: Biological Actions and Clinical RelevanceLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer Netherlands

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Evidence for a role of the FXR-driven intestinal regulatory factor FGF-19 upon cholestyramine and chenodeoxycholic acid treatment and during the diurnal regulation of bile acid synthesis in humans

Insights into the regulation of expression of human OSTα-OSTβ

Role of polymorphisms in genes involved in bile acid detoxification pathways in primary sclerosing cholangitis

Ursodeoxycholic acid-disulphate (SUDCA) — a potent chemopreventive agent against colon cancer

Bile acids enhance cellular motility of the hepatic myofibroblast-like cell through the regulation of p38/JNK signalling

Primary sclerosing cholangitis: bile duct and colonie carcinomas after long-term ursodeoxycholic acid

Prevention of cholesterol gallstones by the potent cholesterol absorption inhibitor ezetimibe in gallstone-susceptible C57L/J mice

Adolf windaus prize lecture: primary biliary cirrhosis: from ursodeoxycholic acid towards targeting strategies for therapies

Falk Symposium - Bile Acids: Biological Actions and Clinical Relevance
Latest Publications